Personalized CDS for Heart Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve how doctors decide on treatments for heart failure with reduced ejection fraction (HFrEF), a condition where the heart doesn't pump effectively. Researchers are testing a new tool called Personalized Clinical Decision Support (CDS), which provides doctors with the most relevant advice based on their past prescribing habits. The goal is to help doctors make better treatment choices by eliminating unnecessary information. The trial seeks doctors who can prescribe medication and work in cardiology or primary care clinics at UCHealth. As an unphased trial, this study offers the opportunity to contribute to innovative research that could enhance treatment decisions for heart failure patients.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this clinical decision support is safe for heart failure management?
Research has shown that clinical decision support (CDS) tools, like those in this trial, are generally safe. They assist doctors in making quicker and better decisions, particularly in heart failure care. Studies have found that most doctors believe these tools can enhance patient treatment, leading to improved health outcomes.
No reports of serious harm have emerged from using these digital tools, with the focus on enhancing their effectiveness. Unlike drugs or surgeries, these tools do not carry the same risks. The personalized CDS being tested aims to provide doctors with useful information based on their past choices. No evidence suggests that using these tools could cause harm; they are designed to guide and improve decision-making.
In summary, while the trial tests the effectiveness of the personalized CDS, existing evidence indicates no significant safety risk to participants.12345Why are researchers excited about this trial?
Researchers are excited about the Personalized Clinical Decision Support (CDS) for heart failure because it tailors treatment recommendations to individual patient data, potentially improving outcomes compared to traditional methods. Unlike standard care options that often apply a one-size-fits-all approach, this personalized system uses advanced algorithms to consider a patient's unique health profile and treatment history. By offering more precise guidance to healthcare providers, it aims to enhance decision-making and optimize patient care.
What evidence suggests that this trial's clinical decision support tools could be effective for heart failure?
Research has shown that special computer systems, known as clinical decision support (CDS) systems, can help doctors manage heart failure more effectively. In this trial, participants will receive either Personalized Clinical Decision Support (CDS) or Traditional Clinical Decision Support (CDS). These personalized tools provide doctors with specific information, eliminating unnecessary details. Studies have found that these systems can reduce "alert fatigue," which occurs when doctors receive too many alerts and begin to ignore them. They also help doctors prescribe medications more accurately, leading to better treatment for heart failure with reduced ejection fraction (HFrEF) than traditional methods. Most doctors believe these systems can improve treatment in emergency situations and lead to better patient outcomes.24678
Who Is on the Research Team?
Katy E Trinkley, PharmD, PhD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for clinicians with prescribing privileges at UCHealth's outpatient cardiology or primary care clinics. It aims to observe and improve their prescribing behaviors, especially in the context of heart failure treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of personalized and traditional clinical decision support (CDS) tools to evaluate their effectiveness in prescribing guideline-directed management and therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF)
Follow-up
Participants are monitored for the effectiveness of CDS tools in improving prescription practices
What Are the Treatments Tested in This Trial?
Interventions
- Personalized Clinical Decision Support (CDS)
- Traditional Clinical Decision Support (CDS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor